Valuation: Kenvue Inc.

Market Cap 34.21B 29.83B 28.17B 25.58B 47.92B 3,283B 48.12B 337B 130B 1,669B 129B 126B 5,370B P/E 2026 *
18.8x
P/E 2027 * 16.3x
Enterprise Value 41.31B 36.02B 34.01B 30.89B 57.87B 3,964B 58.11B 407B 157B 2,015B 155B 152B 6,484B EV / Sales 2026 *
2.65x
EV / Sales 2027 * 2.55x
Free-Float
98.88%
Yield 2026 *
4.74%
Yield 2027 * 4.84%
1 day-0.34%
1 week+0.17%
Current month-5.67%
1 month-5.27%
3 months-1.71%
6 months+1.71%
Current year+3.25%
1 week 17.7
Extreme 17.7
18.2
1 month 17.6
Extreme 17.6
19.56
Current year 16.56
Extreme 16.555
20.13
1 year 14.02
Extreme 14.02
20.13
3 years 14.02
Extreme 14.02
25.17
5 years 14.02
Extreme 14.02
27.8
10 years 14.02
Extreme 14.02
27.8
Manager TitleAgeSince
Chief Executive Officer 56 2025-07-13
Director of Finance/CFO 48 2026-05-11
Chief Tech/Sci/R&D Officer 57 -
Director TitleAgeSince
Chairman 70 2023-04-30
Director/Board Member 66 2023-05-03
Director/Board Member 59 2023-05-07
Date Insider Type Main position Quantity % Market Cap. Importance
7/31/26 Exercice

Executive/Senior Manager

32,838 0.0017%
5/21/26 Free

Director

10,309 0.0005%
5/21/26 Free

Chairman

16,036 0.0008%
Change 5-day change 1-year change 3-year change Capi.($)
-0.34%+0.17%-1.60%-15.51% 34.32B
-0.79%+0.77%-6.95%-4.97% 343B
-0.25%+1.53%-9.72%+0.11% 133B
-0.30%+0.77%+7.29%+18.44% 69.94B
-0.53%+0.26%-25.31%-22.37% 47.65B
-0.46%-3.80%+6.17%-39.41% 33.96B
-0.43%+2.69%+2.96%+23.09% 20.28B
-0.99%+1.34%-18.80%-39.15% 18.79B
-1.02%+0.11%+7.13%+7.92% 18.24B
+0.80%+1.73%-28.94%-11.41% 9.33B
Average -0.43%+0.36%-6.78%-8.32% 72.84B
Weighted average by Cap. -0.57%+0.66%-6.39%-4.89%

Financials

2026 *2027 *
Net sales 15.6B 13.6B 12.84B 11.66B 21.85B 1,496B 21.94B 154B 59.36B 761B 58.58B 57.28B 2,448B 15.97B 13.92B 13.15B 11.94B 22.37B 1,532B 22.46B 157B 60.77B 779B 59.98B 58.65B 2,506B
Net income 1.83B 1.59B 1.5B 1.37B 2.56B 175B 2.57B 18.02B 6.95B 89.13B 6.86B 6.71B 287B 2.1B 1.83B 1.73B 1.57B 2.94B 202B 2.96B 20.73B 8B 103B 7.9B 7.72B 330B
Net Debt 7.1B 6.19B 5.85B 5.31B 9.95B 681B 9.99B 70.02B 27.02B 346B 26.67B 26.08B 1,114B 6.53B 5.7B 5.38B 4.88B 9.15B 627B 9.19B 64.43B 24.86B 319B 24.54B 23.99B 1,025B
Logo Kenvue Inc.
Kenvue Inc. is one of the world leaders in the design, manufacture and marketing of consumer healthcare products. The group offers products for health, beauty, baby care, oral care, skin care and more. Net sales break down by family of products as follows: - self care products (42,3%): for the treatment of coughs, colds, allergies, pain, indigestion, constipation, etc. (brands Zyrtec, Benadryl, Zarbee's, Frenadol, Codral, Reactine, Tylenol, Motrin, Calpol, Nicorette, Imodium, Pepcid, Microlax, Daktarin, etc.); - personal care products (30.3%): primarily oral care, baby care, women's health and wound care products (Listerine, Desitin, Carefree, Stayfree, Band-Aid, Neosporin brands, etc.); - beauty and skin care products (27.4%): hair care products, sun protection products, face and body care products, etc. (Neutrogena, Aveeno, Clean&Clear, Lubriderm, Johnsons, Neostrata, OGX, Rogaine brands, etc.). Product marketing is assured through direct sales, distributors and the Internet. Net sales are distributed geographically as follows: North America (49%), Europe-Middle East-Africa (23%), Asia-Pacific (19.3%) and Latin America (8.7%).
Employees
21,890
Date Price Change Volume
26-09-18 US$17.81 -0.34% 26,721,584
26-09-17 US$17.87 +0.22% 23,452,764
26-09-16 US$17.83 -0.50% 23,064,951
26-09-15 US$17.92 +0.06% 53,825,344
26-09-14 US$17.91 +0.73% 40,652,820
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
14
Last Close Price
17.81USD
Average target price
19.50USD
Spread / Average Target
+9.49%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. KVUE Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!